Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.66 CAD
Market Closed
Updated:
May 14, 2024
Theratechnologies Inc
Operating Expenses
|
Theratechnologies Inc
Operating Expenses Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Operating Expenses
-$65.3m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-18%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Operating Expenses
-$214.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Expenses
-$167.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Operating Expenses
-$101.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Expenses
-$238.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-40%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Expenses
-CA$12.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
See Also
What is Theratechnologies Inc's Operating Expenses?
Operating Expenses
-65.3m
USD
-65.3m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Operating Expenses amounts to -65.3m USD.
What is Theratechnologies Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-18%
-18%
Over the last year, the Operating Expenses growth was 31%. The average annual Operating Expenses growth rates for Theratechnologies Inc have been -4% over the past three years , -12% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
